Type1diabetes: Clinical Trials

4 trials for Type1diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Completed 2, Recruiting 1, Unknown 1

Follow Type1diabetes: new trials by email Literature Review of Type1diabetes trials Research Report on Type1diabetes

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
UP421 - Type1diabetes
Early Phase 1RecruitingPer-Ola Carlsson22024-03-082024-12-11
Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients
Aspart insulin - Type1diabetes
Early Phase 1CompletedYale University32020-01-012023-08-14
Stem Cells From Human Exfoliated Teeth in Treatment of Diabetic Patients With Significantly Reduced Islet Function
Stem cells from human exfoliated teeth - Type1diabetes
Early Phase 1UnknownCAR-T (Shanghai) Biotechnology Co., Ltd.242019-01-052019-04-22
Adrenergic System in Islet Transplantation
Phentolamine, Propranolol, Placebo - Type1diabetes, Hypoglycemia
Early Phase 1CompletedUniversity of Pennsylvania92017-01-202026-04-27

Narrower conditions

Hypoglycemia (1)

Broader conditions

Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Insulin Aspart (1)  ·  Phentolamine (1)  ·  Propranolol (1)  ·  Sodium Chloride (1)

Sponsors

CAR-T (Shanghai) Biotechnology Co., Ltd. (1)  ·  Per-Ola Carlsson (1)  ·  University of Pennsylvania (1)  ·  Yale University (1)

Countries

United States (2)  ·  China (1)  ·  Sweden (1)

Top investigators

Jennifer Sherr, MD (1)  ·  Michael R Rickels, MD., MS (1)  ·  Per-Ola Carlsson, MD, PhD (1)  ·  Qin Huang, Doctor (1)

Results publications

PMID 40757665

NIH funding

2023 (1), R01DK091331 (1)